Uy G - Search Results

1

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.

Ramsingh G, Westervelt P, McBride A, Stockerl-Goldstein K, Vij R, Fiala M, Uy G, Cashen A, Dipersio JF, Abboud CN. Ramsingh G, et al. Among authors: uy g. Int J Hematol. 2014 Mar;99(3):272-8. doi: 10.1007/s12185-014-1503-4. Epub 2014 Feb 2. Int J Hematol. 2014. PMID: 24488798 Free PMC article. Clinical Trial.

2

The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma.

Uy GL, Tomasson MH, Ruddell A, DiPersio JF, Vij R. Uy GL, et al. Haematologica. 2006 Nov;91(11):1581-2. Epub 2006 Oct 17. Haematologica. 2006. PMID: 17043015

3

Bortezomib inhibits osteoclast activity in patients with multiple myeloma.

Uy GL, Trivedi R, Peles S, Fisher NM, Zhang QJ, Tomasson MH, DiPersio JF, Vij R. Uy GL, et al. Clin Lymphoma Myeloma. 2007 Nov;7(9):587-9. doi: 10.3816/clm.2007.n.045. Clin Lymphoma Myeloma. 2007. PMID: 18186967 Clinical Trial.

4

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF. Pusic I, et al. Biol Blood Marrow Transplant. 2008 Sep;14(9):1045-1056. doi: 10.1016/j.bbmt.2008.07.004. Biol Blood Marrow Transplant. 2008. PMID: 18721768 Free article.

5

Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.

Uy GL, Rettig MP, Cashen AF. Uy GL, et al. Expert Opin Biol Ther. 2008 Nov;8(11):1797-804. doi: 10.1517/14712598.8.11.1797. Expert Opin Biol Ther. 2008. PMID: 18847313 Review.

6

Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.

Uy GL, Goyal SD, Fisher NM, Oza AY, Tomasson MH, Stockerl-Goldstein K, DiPersio JF, Vij R. Uy GL, et al. Bone Marrow Transplant. 2009 May;43(10):793-800. doi: 10.1038/bmt.2008.384. Epub 2008 Nov 24. Bone Marrow Transplant. 2009. PMID: 19029964 Clinical Trial.

7

Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.

Martin MG, Dipersio JF, Uy GL. Martin MG, et al. Among authors: uy gl. Leuk Lymphoma. 2009 Jan;50(1):14-23. doi: 10.1080/10428190802517765. Leuk Lymphoma. 2009. PMID: 19117213 Review.

8

Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.

Martin MG, Uy GL, Procknow E, Stockerl-Goldstein K, Cashen A, Westervelt P, Abboud CN, Augustin K, Luo J, DiPersio JF, Vij R. Martin MG, et al. Among authors: uy gl. Bone Marrow Transplant. 2009 Jul;44(1):13-7. doi: 10.1038/bmt.2008.423. Epub 2009 Jan 12. Bone Marrow Transplant. 2009. PMID: 19139740 Clinical Trial.

9

Plerixafor.

DiPersio JF, Uy GL, Yasothan U, Kirkpatrick P. DiPersio JF, et al. Nat Rev Drug Discov. 2009 Feb;8(2):105-6. doi: 10.1038/nrd2819. Nat Rev Drug Discov. 2009. PMID: 19180104 No abstract available.

10

A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.

Martin MG, Walgren RA, Procknow E, Uy GL, Stockerl-Goldstein K, Cashen AF, Westervelt P, Abboud CN, Kreisel F, Augustin K, Dipersio JF, Vij R. Martin MG, et al. Among authors: uy gl. Am J Hematol. 2009 Sep;84(9):560-4. doi: 10.1002/ajh.21482. Am J Hematol. 2009. PMID: 19650118 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page